MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s40360-025-01039-2

Медицинская библиотека · BMC pharmacology & toxicology · 2025

Innovative approach in Parkinson's targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study.

Nematalla Hisham A, Elharoun Mona, Abd-Alhaseeb Mohammad M, Sharafeldin Hend A, Elsheikh Manal A, Abbas Haidy, Elkelish Amr, Dossouvi Komla Mawunyo, Mehana Amir E, Abdelgawad Fathy Elsayed, Zewail Mariam

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Tremors and rigid muscles are symptoms of Parkinson's disease (PD), which affects about 1% of the global population.

PURPOSE: To investigate the integrated therapeutic benefits of the phytopharmaceutical berberine and mucoadhesive nanoliposomes, administered via the nose-to-brain route, to enhance bioavailability, facilitate blood-brain barrier penetration, and augment efficacy against neurodegenerative progression in Parkinson's disease (PD).

STUDY

DESIGN

This study aimed to develop and characterize chitosan-decorated liposomes (chitosomes) loaded with berberine (BER) for targeted brain delivery via the intranasal route.

METHODS

In vitro characterization of BER loaded chitosomes was conducted including measurement of particle size, zeta potential, EE % and in vitro drug release. The optimized formulation was intranasally administered in rats with rotenone-induced PD animal model, motor function and coordination were investigated besides testing the levels of different biomarkers and histopathological examination.

RESULTS

The prepared chitosomes had a particle size of 312 nm, zeta potential of 34 mV, and high encapsulation efficiency (89.3%) and sustained drug release. In vivo assessments conducted in a rotenone-induced PD animal model revealed notable improvements in motor function and coordination. Biochemical evaluations showed that BER chitosomes reduced α-synuclein by 49% and raised dopamine levels by 55% as compared to the model group. Additionally, BER chitosomes significantly decreased oxidative stress markers by a 67% decrease in NF-κB levels and a one-fold increase in Nrf2. Histological examination showed a noticeable reduction in neuronal degeneration and Lewy body formation.

CONCLUSION

Our findings imply that BER chitosomes are a viable intranasal delivery tool for the efficient treatment of PD due to their enhanced bioavailability. and greater nasal mucosa penetration.

Для цитирования: Nematalla Hisham A, Elharoun Mona, Abd-Alhaseeb Mohammad M, Sharafeldin Hend A, Elsheikh Manal A, Abbas Haidy, Elkelish Amr, Dossouvi Komla Mawunyo, Mehana Amir E, Abdelgawad Fathy Elsayed, Zewail Mariam. Innovative approach in Parkinson's targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study.. BMC pharmacology & toxicology. 2025. DOI: 10.1186/s40360-025-01039-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.